Final Results of a Phase II Study of Sunitinib As Second Line Therapy of Malignant Pleural Mesothelioma (MPM)

A. K. Nowak; R. J. Francis; M. J. Millward; A. van der Schaaf; T. Seguard; J. Creaney; A. Hasani; A. W. Musk; M. J. Byrne

doi:10.1097/01.JTO.0000394634.73009.dc

Final Results of a Phase II Study of Sunitinib As Second Line Therapy of Malignant Pleural Mesothelioma (MPM)

A. K. Nowak, R. J. Francis, M. J. Millward, A. van der Schaaf, T. Seguard, J. Creaney, A. Hasani, A. W. Musk, M. J. Byrne

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S12-S12
Number of pages	1
Journal	Journal of Thoracic Oncology
Volume	6
Issue number	3
DOIs	https://doi.org/10.1097/01.JTO.0000394634.73009.dc
Publication status	Published - Mar 2011
Event	3rd Australian Lung Cancer Conference (ALCC) - Melbourne, Australia Duration: 7 Oct 2010 → 9 Oct 2010

Access to Document

10.1097/01.JTO.0000394634.73009.dc

Cite this

@article{86da491faced459bad9bac9a23ef8f72,

title = "Final Results of a Phase II Study of Sunitinib As Second Line Therapy of Malignant Pleural Mesothelioma (MPM)",

author = "Nowak, {A. K.} and Francis, {R. J.} and Millward, {M. J.} and {van der Schaaf}, A. and T. Seguard and J. Creaney and A. Hasani and Musk, {A. W.} and Byrne, {M. J.}",

year = "2011",

month = mar,

doi = "10.1097/01.JTO.0000394634.73009.dc",

language = "English",

volume = "6",

pages = "S12--S12",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Academic Press",

number = "3",

note = "3rd Australian Lung Cancer Conference (ALCC), ALCC ; Conference date: 07-10-2010 Through 09-10-2010",

}

TY - JOUR

T1 - Final Results of a Phase II Study of Sunitinib As Second Line Therapy of Malignant Pleural Mesothelioma (MPM)

AU - Nowak, A. K.

AU - Francis, R. J.

AU - Millward, M. J.

AU - van der Schaaf, A.

AU - Seguard, T.

AU - Creaney, J.

AU - Hasani, A.

AU - Musk, A. W.

AU - Byrne, M. J.

PY - 2011/3

Y1 - 2011/3

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000287990600043&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1097/01.JTO.0000394634.73009.dc

DO - 10.1097/01.JTO.0000394634.73009.dc

M3 - Abstract/Meeting Abstract

SN - 1556-0864

VL - 6

SP - S12-S12

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 3

T2 - 3rd Australian Lung Cancer Conference (ALCC)

Y2 - 7 October 2010 through 9 October 2010

ER -

Final Results of a Phase II Study of Sunitinib As Second Line Therapy of Malignant Pleural Mesothelioma (MPM)

Access to Document

Other files and links

Cite this